pyramidatine

a cinnamic acid-derived bisamide compound isolated from the leaves of Aglaia perviridis

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Mouth Neoplasms (Oral Cancer) 01/01/2018 - "Pyramidatine (Z88) Sensitizes Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells to Chemotherapeutic Agents by Inhibition of P-glycoprotein." 01/01/2018 - "In the present study, we aim to determine the anti-MDR effects of pyramidatine (Z88), a cinnamic acid-derived bisamide compound isolated from the leaves of Aglaia perviridis, on KB/VCR (vincristineresistant human oral cancer cells) and MCF-7/ADR (adriamycin-resistant human breast adenocarcinoma) cells. "
2.	Adenocarcinoma 01/01/2018 - "In the present study, we aim to determine the anti-MDR effects of pyramidatine (Z88), a cinnamic acid-derived bisamide compound isolated from the leaves of Aglaia perviridis, on KB/VCR (vincristineresistant human oral cancer cells) and MCF-7/ADR (adriamycin-resistant human breast adenocarcinoma) cells. "

1.	Doxorubicin (Adriamycin)
2.	cinnamic acid
3.	Member 1 Subfamily B ATP Binding Cassette Transporter
4.	Vincristine (Oncovin)